Abstract
The present study was performed to investigate the enzyme inhibitory and antidiabetic activities of the constituents isolated from Callistemon lanceolatus. The leaves of C. lanceolatus were extracted with successively with petroleum ether, dichloromethane and methanol. The dried dichloromethane and methanol extracts were subjected to fractionation and chromatographic separation, which led to the isolation of seven compounds: 3-epi-betulinic acid (1), 3- epi-ursolic acid (2), oleanolic acid (3), ursolic acid (4), lup-12, 20(29)-diene-3α-ol-28-oic acid (5), heptacosenone (6) and kaempferol (7). Their structures were elucidated on the basis of spectroscopic studies as well as by comparison with the data available in the literature. Among these isolates, compounds 1, 2, 3, 4 and 7 were evaluated for in vitro enzyme inhibition effect. Compounds 1, 2, 3, 4 and 7 showed 38.34, 52.59, 62.4, 54.95 and 32.43 % α-amylase inhibition respectively and 49.27, 53.34, 84.2, 67.98 and 52.25 % α-glucosidase inhibition respectively at the concentration of 50 µg/kg. Compounds 3, 4 and 7 were also showed antidiabetic activity in streptozotocin-nicotinamide induced diabetic mice at the dose of 10 mg/kg.
Keywords: α-amylase inhibition, antidiabetic, Callistemon lanceolatus, α-glucosidase inhibition, streptozotocin-nicotinamide, ursolic acid.
The Natural Products Journal
Title:Enzymes Inhibition and Antidiabetic Effect of Isolated Constituents from Callistemon lanceoalatus
Volume: 3 Issue: 4
Author(s): Sunil Kumar, Vipin Kumar, Om Prakash and Mohammed Ali
Affiliation:
Keywords: α-amylase inhibition, antidiabetic, Callistemon lanceolatus, α-glucosidase inhibition, streptozotocin-nicotinamide, ursolic acid.
Abstract: The present study was performed to investigate the enzyme inhibitory and antidiabetic activities of the constituents isolated from Callistemon lanceolatus. The leaves of C. lanceolatus were extracted with successively with petroleum ether, dichloromethane and methanol. The dried dichloromethane and methanol extracts were subjected to fractionation and chromatographic separation, which led to the isolation of seven compounds: 3-epi-betulinic acid (1), 3- epi-ursolic acid (2), oleanolic acid (3), ursolic acid (4), lup-12, 20(29)-diene-3α-ol-28-oic acid (5), heptacosenone (6) and kaempferol (7). Their structures were elucidated on the basis of spectroscopic studies as well as by comparison with the data available in the literature. Among these isolates, compounds 1, 2, 3, 4 and 7 were evaluated for in vitro enzyme inhibition effect. Compounds 1, 2, 3, 4 and 7 showed 38.34, 52.59, 62.4, 54.95 and 32.43 % α-amylase inhibition respectively and 49.27, 53.34, 84.2, 67.98 and 52.25 % α-glucosidase inhibition respectively at the concentration of 50 µg/kg. Compounds 3, 4 and 7 were also showed antidiabetic activity in streptozotocin-nicotinamide induced diabetic mice at the dose of 10 mg/kg.
Export Options
About this article
Cite this article as:
Kumar Sunil, Kumar Vipin, Prakash Om and Ali Mohammed, Enzymes Inhibition and Antidiabetic Effect of Isolated Constituents from Callistemon lanceoalatus, The Natural Products Journal 2013; 3 (4) . https://dx.doi.org/10.2174/221031550304140328112456
DOI https://dx.doi.org/10.2174/221031550304140328112456 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dietary Carotenoids in Managing Metabolic Syndrome and Role of PPARs in the Process
Current Nutrition & Food Science Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?
Current Hypertension Reviews Editorial [Hot Topic: Heart Transplantation in Congenital Heart Disease (Guest Editor: Francesco Parisi)]
Current Cardiology Reviews Anti-Angiogenic Treatment for Exudative Age-Related Macular Degeneration: New Strategies are Underway
Current Angiogenesis (Discontinued) Acknowledgements to Reviewers
Current Hypertension Reviews Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A Population Based Case-Control Study
Current Alzheimer Research Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway
Current Pharmacogenomics Delayed Neuroleptic Malignant Syndrome Associated with the Use of Low Dose Risperidone in Conjunction with Cholinergic Drugs-the Dangers of Polypharmacy in the Elderly
Current Drug Therapy Decreased Cerebral Perfusion and Oxidative Stress Result in Acute and Delayed Cognitive Impairment
Current Neurovascular Research Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients
Current Diabetes Reviews Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats
Current Gene Therapy Platelet Function and Signaling in Diabetes Mellitus
Current Vascular Pharmacology Subject Index To Volume 4
Current Pharmacogenomics Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization
Current Vascular Pharmacology Nitrones: A Potential New Alternative as Therapeutic Agents
Current Organic Chemistry The Impact of Body Mass Index and Type 2 Diabetes on Breast Cancer: Current Therapeutic Measures of Prevention
Current Drug Targets - Immune, Endocrine & Metabolic Disorders A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin
Current Drug Targets